Spots Global Cancer Trial Database for Glizigen-Viudid-External Anogenital Warts in Children and Adolescents
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Glizigen-Viudid-External Anogenital Warts in Children and Adolescents
Official Title: Efficacy of Glizigen-Viudid in the Treatment of External Anogenital Warts in Children and Adolescents.
Study ID: NCT01111344
Conditions
Study Description
Brief Summary: The purpose of the study is to assess the efficacy of Glizigen and Viusid administration in the treatment of external anogenital warts in children and adolescents. The duration of this double-blind placebo controlled phase 3 clinical trial will be 12 weeks. The estimated number of persons to be recruited and randomized for the study is 76. Variables to be assessed will be: time to disappearance of lesions, reduction of the number of lesions and change in the aspect of lesions.
Detailed Description:
Eligibility
Minimum Age: 10 Years
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Pediatric Hospital "Dr. Juan Manuel Márquez"., Havana, , Cuba
Contact Details
Name: Edelisa Moredo Romo, MD
Affiliation: Pediatric Hospital "Dr. Juan Manuel Márquez.
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
